UTHR
UNITED THERAPEUTICS Corp
UNITED THERAPEUTICS Corp (UTHR) has 49 SEC Form 4 filings (500 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 16, 2026.
The most active filer is Chairperson & CEO ROTHBLATT MARTINE A with 33 filings. Insiders have net sold $221.5M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Martine A. Rothblatt
- Employees:1,305
- HQ:Silver Spring, MD, US
- IPO:1999-06-17
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$221.5M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$22.5B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| EVP & GENERAL COUNSEL | Sale | 8,300 | $4.4M | Jul 16 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Jul 16 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Jul 15 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.1M | Jul 14 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Jul 13 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Jul 10 | SEC ↗ | |
MALCOLM JANFirst filing | Director | Sale | 325 | $179K | Jul 10 | SEC ↗ |
| Chairperson & CEO | Sale | 9,500 | $5.3M | Jul 9 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.3M | Jul 8 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Jul 7 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.3M | Jul 2 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Jul 2 | SEC ↗ | |
| EVP & GENERAL COUNSEL | Sale | 8,300 | $4.6M | Jul 2 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.1M | Jul 1 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Jun 30 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Jun 29 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Jun 26 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Jun 25 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.1M | Jun 24 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Jun 24 | SEC ↗ | |
| CFO AND TREASURER | Sale | 8,750 | $4.7M | Jun 23 | SEC ↗ | |
| CFO AND TREASURER | Sale | 10,000 | $5.4M | Jun 22 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.1M | Jun 22 | SEC ↗ | |
MAHON PAUL AFirst in 10 months | EVP & GENERAL COUNSEL | Sale | 8,300 | $4.5M | Jun 18 | SEC ↗ |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Jun 18 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Jun 17 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Jun 9 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.5M | May 14 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.4M | May 12 | SEC ↗ | |
| CFO AND TREASURER | Sale | 10,000 | $5.7M | May 12 | SEC ↗ | |
| CFO AND TREASURER | Sale | 10,000 | $5.8M | May 11 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.5M | May 11 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.5M | May 6 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.4M | May 4 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.4M | May 1 | SEC ↗ | |
| CFO AND TREASURER | Sale | 10,000 | $5.7M | May 1 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.4M | Apr 28 | SEC ↗ | |
| CFO AND TREASURER | Sale | 10,000 | $5.7M | Apr 28 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.4M | Apr 22 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.6M | Apr 20 | SEC ↗ | |
| CFO AND TREASURER | Sale | 10,000 | $5.8M | Apr 17 | SEC ↗ | |
| Chairperson & CEO | Sale | 75 | $40K | Apr 16 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.5M | Apr 16 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.5M | Apr 16 | SEC ↗ |
Related companies
UNITED THERAPEUTICS Corp is in the Healthcare sector.